Allied Irish Banks plc (NYSE:AIB) issued its trading performance and financial position. Asset disposals are continuing to change the bank's business mix. At the beginning of this month shareholders agreed to the sale of our 22.4% stake in M&T which completed on 4(th) November 2010. The sale of our Polish interests has also been agreed subject to shareholder and regulatory approval. Accordingly, trading commentary in this statement does not include the performance of these two businesses.The bank published certain key targets (including a cumulative non-NAMA credit charge for the three years 2010 to 2012) with the announcement of its results for the six months ended 30(th) June 2010. In light of subsequent developments, those targets are being re-evaluated by us as part of a comprehensive review of the bank's plans being undertaken under the leadership of our new Executive Chairman. Further details of these plans will be published in due course.
Allied Irish Banks, p.l.c., together with its subsidiaries, provides retail and corporate banking, investment banking, and asset management services in the Republic of Ireland and internationally. The company accepts demand deposits, time deposits, and current accounts, as well as provides lending services, such as vehicle, plant, machinery, and equipment leasing; retail and investment property loans; vehicle, plant, machinery, and equipment hire purchase; and personal loans.
Crown Equity Holdings Inc. (OTCBB:CRWE) is pleased to report its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009. The Company incurred an operating loss of $54,527 for the nine months ending September 30, 2010 compared to an operating loss of $36,923 during the same period in 2009. Net loss of $343,049 for the nine months ending September 30, 2010 compared to a net loss of $29,379 for the same period in 2009. The net loss in 2010 was attributed mostly to an unrealized loss of $307,544 on securities held by the Company.
Crown Equity Holdings Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients. The company announced in June of this year its 1- 10 forward stock split.
Global Hunter Corp. (TSX.V: BOB) (FSE:G5D) currently operates an 18,000 + hectare land package in the coastal belt of Chile’s Andean Cordillera the Chilean Iron-Copper Belt. Their current project in this region is the La Corona de Cobre. Global Hunter’s focus is on strategic and base metals, particularly copper and molybdenum.
The Andes rose to fame for its mineral wealth during the Spanish conquest of South America; Although the Andean Amerindian people crafted ceremonial jewelry of gold and other metals the mineralization of the Andes were first mined in large scale after the Spanish arrival. Potosí in present-day Bolivia was one of the principal mines of the Spanish Empire in the New World. Río de la Plata and Argentina derive their names from the silver of Potosí.
Currently, mining in the Andes of Chile and Peru, place these countries as the 1st and 3rd major producers of copper in the world. The Bolivian Andes produce principally tin although historically silver mining had a large impact on the economy of 17th century Europe.
There is a long history of mining in the Andes, from the Spanish silver mines in Potosí in the 16th century to the vast current porphyry copper deposits of Chuquicamata and Escondida in Chile and Toquepala in Peru. Other metals including iron, gold and tin in addition to non-metallic resources are also important.
To learn more about Global Hunter Corp. visit: http://www.globalhunter.ca
Motorola Inc. (NYSE:MOT) announced that it has entered into an agreement with Kopin Corporation (Nasdaq:KOPN) to develop a hands-free computer and communications headset. This new device category is a head-worn, mobile computer headset with full voice, audio and PC capabilities, leveraging Kopin’s advanced system and micro-display technologies to create a virtual 15-inch monitor that supports simulation software, streaming video on-demand and other large-screen enterprise applications. Jeffrey Jacobsen, Senior Advisor to CEO and Golden-i Program Manager, Kopin Corporation, “The Golden-i(NYSE:R) platform offers spontaneous mobile access to virtually any digital information in the world, on-demand. Imagine leaving your laptop at the office and still having full access to all of its information, applications and services while traveling. The Golden-i platform will truly change the way people work and live.”Tom Bianculli, Senior Director, Emerging Business, Chief Technology Office, Motorola Solutions, “We believe this computer headset will be a game-changing solution for mobile workforces and represents the future in wearable computing. As the leader in enterprise mobile computing, Motorola Solutions is working with Kopin to explore new innovations and cutting-edge technologies that will help our customers continue to improve their operational efficiency and increase their productivity."
Motorola, Inc. offers technologies, products, and services for mobile communications worldwide. It operates in three segments: Mobile Devices, Home and Networks Mobility, and Enterprise Mobility Solutions. The Mobile Devices segment designs, manufactures, sells, and services wireless handsets, including smartphones, with integrated software and accessory products, as well as licenses intellectual property.
Boston Scientific Corporation (NYSE:BSX) announced CE Mark approval of its INCEPTA™, ENERGEN™ and PUNCTUA™ cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs). They are the Company's latest devices to treat heart failure and sudden cardiac death. These next-generation products are designed to advance patient care with options to expand appropriate therapy, optimize ventricular pacing and manage heart failure. They are the world's smallest and thinnest high-energy devices and offer extended longevity over legacy platforms. The first implants of INCEPTA™ ICDs and CRT-Ds occurred in Berlin, Germany at the Deutsches Herzzentrum Berlin (Stephan Goetze, M.D., Professor of Medicine); Herne, Germany at the Katholisches Marienhospital Herne (Hans-Joachim Trappe, M.D., Professor of Medicine); Linz, Austria at the Krankenhaus der Elisabethinen Linz (Siegmund Winter, M.D.); and Maastricht, The Netherlands at the Academisch Ziekenhuis Maastricht (An Moens, M.D.). These initial implants are part of the NOTICE-HF study, which will evaluate and document the performance of the devices before full commercial launch, expected in the U.S., the Europe/Middle East/Africa region and certain Inter-Continental countries in the first half of next year.
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. It offers cardiac rhythm management products, which monitor the heart and deliver electricity to treat cardiac abnormalities; and RF generators, intracardiac ultrasound and steerable ablation catheters, and diagnostic catheters for the diagnosis and treatment of cardiac arrhythmias.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from Global Hunter Corp. (TSX Venture Exchange (TSX.V:BOB) and the Frankfurt Stock Exchange (FSE:G5D)) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company.